Clinical and biological characteristics of multiple myeloma with 1q21 amplification
Clinical and biological characteristics of multiple myeloma with 1q21 amplification
摘要
Objective To study the clinical features of multiple myeloma(MM)patients with 1q21 amplification and the detection and biological characteristics of 1q21 copy number variation among different stages of plasma cell dyscrasias.Methods We analyzed the amplification
-
1Dinesh Chandra Doval,Komal Bhatia,Ashok Kumar Vaid,Kumar Prabhash,Amarnath Jena,Digant Hazarika.Bone metastases from primary hepatocellular carcinoma simulating multiple myeloma[J].Hepatobiliary & Pancreatic Diseases International,2005,4(2):308-310.
-
2潘荣南,陈民,吴雪松,李文.误诊为脑膜瘤的多发性骨髓瘤2例并文献复习[J].中国临床新医学,2009,2(3):278-279. 被引量：2
-
3王云侠,杨瑾瑾,霍翠媛,于梅杰.硼替佐米治疗多发性骨髓瘤的观察与护理[J].中日友好医院学报,2015,29(2):127-127. 被引量：3
-
4Ge Yan, Xiaoyan Zhou, Xiuying Xiao, Hongfen Lu, Xiang Du Department of Pathology, Cancer Hospital, Fudan University,Department of Oncology, Shanghai Medical College, Fudan University,Colorectal Cancer Center, Fudan University, Shanghai 200032, China.Ezrin expression and its translocation in human primary sporadic colorectal carcinoma and prognostic significance[J].The Chinese-German Journal of Clinical Oncology,2007,6(3):232-236.
-
5王娟,张森森,陈丽娟,张启国,周荣富.硼替佐米治疗多发性骨髓瘤并发带状疱疹的临床研究[J].实用老年医学,2013,27(12):1045-1047. 被引量：2
-
6高珊.Culture and regulation of osteoblasts in multiple myeloma patients[J].China Medical Abstracts(Internal Medicine),2014,31(2):122-122.
-
7朱志强,文建国,郑湘予,王道协,王庆伟,樊长辉.Expression of Transcription Factor Oct4 in Bladder Cancer Cell Line T24 and Its Effects on the Biological Characteristics of the Cells[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2009,29(1):73-76. 被引量：3
-
8NEOPLASMS[J].China Medical Abstracts(Internal Medicine),1996,13(1):15-17.
-
9郭琳琅,肖莎,郭颖.The relationship between bcl-2 gene abnormality and nasopharyeal carcinoma[J].Journal of Medical Colleges of PLA(China),1998,13(3):168-170.
-
10任龙喜,程爱国,白俊清.早期多发性骨髓瘤与骨质疏松症(附13例分析)[J].综合临床医学,1992,8(3):136-137.
